Milne Jill C.

CIK 00016442461 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001644246

Recent Transactions

21 trades

Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−761,000→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−195,000→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Common Stock
2026-01-23−4,377→ 0 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2025-03-21+761,000→ 761,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2024-02-08+534,600→ 534,600 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2023-06-02+275,000→ 275,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2022-03-01+195,000→ 195,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2021-06-02+1,400,000→ 1,400,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2020-02-12+150,000→ 150,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2019-02-13+100,000→ 100,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2018-09-07+230,000→ 230,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2018-02-08+230,000→ 230,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2017-02-09+200,000→ 200,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2016-09-08+45,000→ 45,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2016-09-08+45,000→ 45,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2016-02-11+103,000→ 103,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2015-07-17+160,000→ 160,000 total
Conversion
Astria Therapeutics, Inc.$ATXS
Series A Preferred Stock
2015-06-30−856,548→ 0 total
Conversion
Astria Therapeutics, Inc.$ATXS
Common Stock
2015-06-30+8,189→ 253,872 total
Conversion
Astria Therapeutics, Inc.$ATXS
Common Stock
2015-06-30+66,657→ 245,683 total
Conversion
Astria Therapeutics, Inc.$ATXS
Series B Preferred Stock
2015-06-30−105,229→ 0 total

Companies

Astria Therapeutics, Inc.
Director, CEO and President
$ATXS

Recent Filings

Address

C/O ASTRIA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 10TH FLOOR

BOSTON, MA, 02210

View on SEC.gov